Radar › Screener › TCRX

TCRX

TScan Therapeutics, Inc.
TCRX stock: delisting risk — what the SEC filings say, updated every weekday morning.
Nasdaq · Biological Products, (No Diagnostic Substances) · EDGAR filings (CIK 1783328) · 7 signals · 0 setups · updated Sep 22, 2026

What the filings say Pressure ▼

The exchange has started a clock; the company must cure or appeal or it will be delisted.

Radar 68 (elevated attention) · dilution pressure low · listing risk high · governance risk low · runway 11.4 mo · strongest signal: Exchange deficiency notice (Sep 2, 2026)

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

Get tomorrow's read on TCRX — free
One email every weekday morning: what changed across TCRX and ~1,400 other microcaps, every claim linked to the filing.
68Radar · attention score (0–100)
20Dilution pressure · financing + balance sheet
89Listing risk · exchange standards
37Governance risk · reporting, auditor, going concern

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on TCRX
Alerts
One email the morning TCRX files anything that matches your rules (types, minimum score, setups).
12-month history
Every signal and setup for TCRX back a year, not just 30 days — see how the current setup built.
Full analyst notes
What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV
All 892 flagged companies, same-day, sortable and exportable.
Get Pro · $18.85/mo founding rate   See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$100.2Mcash + short-term investments as of Jun 30, 2026
11.4 moestimated runway (annualized 180-day YTD operating cash flow [companyfacts])
$69.0Mstockholders' equity as of Jun 30, 2026
$56.9Mpublic float (10-K cover)
n/ashares outstanding

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 84 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

DateSignalEvidenceScore
Sep 11, 2026· Officer/director change 8-K Item 5.02 filed 2026-09-11 (accepted 08:00 ET) filing 22
Sep 2, 2026▼ Exchange deficiency notice 8-K Item 3.01 filed 2026-09-02 (accepted 07:22 ET) filing 61
Sep 2, 2026▼ Hearings panel “hearings panel” language in 8-K (8-K) filed 2026-09-02 filing 58
Sep 2, 2026▼ Minimum bid deficiency “min bid” language in 8-K (8-K) filed 2026-09-02 filing 48
Sep 2, 2026▼ Delisting language “delisting notice” language in 8-K (8-K) filed 2026-09-02 filing 47
Sep 2, 2026· Officer/director change 8-K Item 5.02 filed 2026-09-02 (accepted 07:22 ET) filing 23
Jun 30, 2026▼ Runway 6–12 months ~11.4 months runway: liquidity $100,156,000 as of 2026-06-30, burn $105,067,278/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing 20
Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans